No Doctoring the Books

31 May 2010 Publication
Authors: Gregory Husisian

Medical Device and Diagnostic Industry

Foley Partner David Simon, Associate Erin Holland, and Of Counsel Gregory Husisian authored an article that appeared in the May 2010 issue of Medical Device and Diagnostic Industry titled “No Doctoring the Books.” Simon, Holland and Husisian discuss how recent government actions make it clear that Foreign Corrupt Practices Act (FCPA) enforcement activities in the pharmaceutical and media device industries are becoming a priority. They note that many industry executives may be surprised to learn that under the broad interpretations of the FCPA adopted by U.S. enforcement agencies, normal marketing and promotional activities directed at physicians, technicians or hospital administrators whose companies are owned or controlled by a foreign government potentially can create FCPA liability. The authors add that conducting an appropriate risk assessment and implementing compliance measures can minimize the FCPA risks inherent to device and pharmaceutical manufacturers.


A Review of Recent Whistleblower Developments
19 July 2019
Legal News: Whistleblower Developments
Blockchain: A Tool With a Future in Healthcare
18 July 2019
Health Care Law Today
Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ